2 ms·
Cool, except right to try is not blinded -- you're paying to have access to drugs, so you have to get them. Any data from a person who buys a drug without knowi
by olliej 8y ago
Cool, except right to try is not blinded -- you're paying to have access to drugs, so you have to get them. Any data from a person who buys a drug without knowing if it works or not (or kills them faster) is useless for everyone else (it actively reduces the trial population) due to placebo effect and trial controls.
This is ignoring 50% being (i would say optimistic) for stage 3 trials, but right to try kicks in before stage 3 trials so suddenly you're dealing with stage 2 trials: and iirc only like 10% of candidates make it from stage 2 to stage 3, so now you've got maybe a 5% chance of it helping, and a much greater chance of it making your situation worse. And you're still not providing useful data that might help other people.
It also ignores that there are typically multiple drugs with the same or similar targets running trials at the same time: which do you take given currently there's no evidence of which (or any) is effective, no data on how dangerous any (or all) of them are.